Sei Investments Co. decreased its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 12.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,181 shares of the medical equipment provider’s stock after selling 8,310 shares during the quarter. Sei Investments Co.’s holdings in Align Technology were worth $9,973,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Sequoia Financial Advisors LLC grew its position in Align Technology by 320.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock worth $1,247,000 after purchasing an additional 6,085 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Align Technology by 35,513.8% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 545,604 shares of the medical equipment provider’s stock worth $85,196,000 after buying an additional 544,072 shares in the last quarter. Capital International Ltd. CA lifted its position in shares of Align Technology by 26.5% during the 4th quarter. Capital International Ltd. CA now owns 57,194 shares of the medical equipment provider’s stock worth $8,931,000 after buying an additional 11,977 shares in the last quarter. Lecap Asset Management Ltd. bought a new position in shares of Align Technology during the 4th quarter worth approximately $1,814,000. Finally, Merit Financial Group LLC boosted its stake in shares of Align Technology by 197.3% in the 4th quarter. Merit Financial Group LLC now owns 8,167 shares of the medical equipment provider’s stock worth $1,275,000 after buying an additional 5,420 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Wall Street Zen lowered Align Technology from a “strong-buy” rating to a “buy” rating in a report on Saturday. Evercore lifted their price target on Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Piper Sandler upped their price objective on Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Finally, Zacks Research lowered Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $206.36.
Align Technology Stock Performance
ALGN stock opened at $169.16 on Friday. The stock has a fifty day moving average of $174.55 and a 200-day moving average of $175.21. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $200.43. The company has a market capitalization of $12.12 billion, a price-to-earnings ratio of 29.42, a PEG ratio of 1.73 and a beta of 1.67.
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.62 by $0.02. The business had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Align Technology had a return on equity of 15.86% and a net margin of 9.99%.The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.49 EPS. Equities analysts predict that Align Technology, Inc. will post 9.48 EPS for the current year.
Align Technology announced that its Board of Directors has approved a share buyback plan on Wednesday, April 29th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 1.6% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Key Align Technology News
Here are the key news stories impacting Align Technology this week:
- Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
- Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
- Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
- Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
- Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
- Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
- Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.
Align Technology Profile
Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.
The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.
Read More
- Five stocks we like better than Align Technology
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
